Bibliography. Current world literature. Therapeutic modalities.
D000227:Adenine Nucleotides; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001087:Arabinonucleosides / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D000077866:Clofarabine; D016207:Cytokines / Q000627:therapeutic use; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D008665:Metalloporphyrins / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000627:therapeutic use; D020123:Sirolimus / Q000627:therapeutic use
D000227:Adenine Nucleotides; D000970:Antineoplastic Agents; D001087:Arabinonucleosides; D019496:Cancer Vaccines; D016207:Cytokines; D005938:Glucocorticoids; D007376:Interleukin-2; D008665:Metalloporphyrins; D019253:Proto-Oncogene Proteins c-bcl-2; D004815:Epidermal Growth Factor; C437683:motexafin gadolinium; D000077866:Clofarabine; D020123:Sirolimus